Marketing-authorisation holder · Canada
Convatec, Division of Bristol-Myers Squibb Canada Co.
3 medicines in 1 country, as authorisation holder.
Medicines
Every medicine in the registers under its name, current ones first.
3 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| LPH GERMICIDAL DETERGENT6.4 % / % + .5 % / % + 3 % / % · Liquid | Clorophene, O-phenylphenol, P-tert-pentylphenol | Canada | Cancelled | 1985 |
| MYCOSTATIN TOPICAL PWR 100,000UNITS/GM100000 unit / g · Powder | Nystatin | Canada | Cancelled | 1994 |
| SHUR-CLENS SOLN 20%20 % · Liquid | Poloxamer | Canada | Cancelled | 1987 |
Countries
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Canada | 3 | 0 | 3 | CompaniesAll medicines |
Therapeutic areas
The ATC groups most of its medicines belong to, largest first.



